Regenxbio Inc (RGNX)

Operating Expenses

$77.71M

Quarterly · Period ending: · USD

RGNX logo

RGNX Operating Expenses

Latest reported$77.71M
RGNX Quarterly Operating Expenses ($620.00K → $77.71M)
High-resolution chart · PNG

RGNX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regenxbio Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
77,714,000
78,681,000
82,045,000
20,318,000
75,523,000
73,449,000
66,264,000
73,888,000
63,702,000
68,921,000
70,543,000
81,486,000
83,610,000
81,183,000
76,333,000
84,463,000
82,231,000
78,028,000
62,001,000
74,016,000
64,442,000
58,075,000
64,839,000
67,597,000
53,715,000
51,935,000
48,301,000
48,102,000
42,826,000
36,761,000
35,484,000
27,514,000
29,809,000
27,958,000
19,020,000
21,962,000
20,301,000
23,286,000
21,835,000
18,758,000
16,829,000
11,548,000
9,044,000
8,226,000
7,349,000
4,584,000
3,196,000
2,147,000
1,002,000
620,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.